Twin,
First patient was enrolled in December 2018 and as of 31
December 2018, no relevant treatment related toxicity has
been observed in the first subject enrolled in the trial. Prelim
inary data from the alloSHRINK Phase 1 trial are expected in
second half 2019
Dus nog wachten tot de 2de helft van 2019.